Danaher Corporation (DHR) Financial Statements

Historical financial data — 42 statements covering FY2016–FY2025

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now f...

Danaher Corporation's revenue increased 2.9% year over year, from $23.88B to $24.57B.

Net income decreased 7.3% over the same period, from $3.90B to $3.61B.

Over the 9-year period from FY2016 to FY2025, revenue grew by 46% in total.

Total debt increased by 15.1% to $18.42B.

The debt-to-equity ratio stands at 0.35, indicating a moderate leverage profile.

Operating cash flow declined 4.1% to $6.42B.

Danaher Corporation maintains a healthy net profit margin of 14.7%.

Recent Financial Statements

Quarterly figures are standalone quarters, de-cumulated from YTD filings (Q4 = FY − Q3 YTD when not reported).

PeriodRevenueNet IncomeGross ProfitEBITOp. Cash FlowTotal AssetsTotal DebtEquity
Q3 FY2024$5.80B+1.0%$818.0M$3.40B$958.0M$1.51B$80.61B$17.52B$51.30B
Q4 FY2024$6.54B+12.8%$1.09B$3.89B$1.43B$2.02B$77.54B$16.00B$49.54B
Q1 FY2025$5.74B-12.2%$954.0M$3.51B$1.27B$1.30B$79.12B$16.48B$50.85B
Q2 FY2025$5.94B+3.4%$555.0M$3.52B$760.0M$1.34B$81.62B$17.36B$52.33B
Q3 FY2025$6.05B+2.0%$908.0M$3.52B$1.15B$1.66B$79.90B$16.86B$51.07B
Q4 FY2025$6.84B+13.0%$1.20B$3.97B$1.50B$2.12B$83.46B$18.42B$52.53B
Q1 FY2026$5.95B-13.0%$1.03B$3.59B$1.34B$1.32B$83.54B$19.68B$52.96B
Q2 FY2026$6.26B+5.3%$870.0M$3.61B$1.13B$1.53B$92.37B$27.86B$52.59B

Balance Sheet Summary (Q2 FY2026)

Total Assets
$92.37B
Total Liabilities
$39.77B
Total Equity
$52.59B
Cash & Equivalents
$4.35B
Total Debt
$27.86B
Current Assets
$13.38B
Current Liabilities
$8.11B
Retained Earnings
$48.23B
Current Price: $229.04
Market Cap: $161.0B
Sector: Healthcare

Danaher Corporation (DHR) Financial Statements & Revenue History

Danaher Corporation (DHR) is a US-listed stock operating in the Healthcare sector, specifically the Diagnostics & Research industry trading at $229.04 with a market capitalization of $161. This page provides 42 historical financial statements for Danaher Corporation, including income statement, balance sheet, and cash flow data across multiple reporting periods. Most recently, Danaher Corporation reported revenue of $24.6 billion, representing 2.9% year-over-year growth. The net profit margin of 14.7% indicates moderate profitability. The debt-to-equity ratio of 0.35 shows conservative leverage.

DHR Income Statement, Balance Sheet & Cash Flow

The financial statements table above shows Danaher Corporation's revenue, net income, gross profit, EBIT, operating cash flow, total assets, total debt, and shareholders' equity across the most recent reporting periods. Year-over-year growth rates help identify whether DHR is accelerating or decelerating in terms of top-line revenue and bottom-line profitability.

  • Revenue trend: Track DHR's top-line growth across quarters and fiscal years to identify acceleration or deceleration in the business.
  • Profitability: Net income and gross profit margins reveal how efficiently Danaher Corporation converts revenue into earnings.
  • Balance sheet health: Total assets, liabilities, debt, and equity provide a snapshot of DHR's financial position and leverage.
  • Cash flow: Operating cash flow shows how much cash the business generates from its core operations, which is critical for funding dividends, buybacks, and growth.

How to Use DHR Financial Data

Investors use Danaher Corporation's financial statements to assess the company's financial health, growth trajectory, and valuation. Key metrics to focus on include:

Financial data is sourced from Danaher Corporation's SEC filings (10-K, 10-Q) via Polygon.io and Finnhub.DHR trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.

Related opportunities

Moving today in Healthcare
More Diagnostics & Research stocks
Cheaper alternatives
Similar fundamentals